Magnesium sulfate is usually the first-line prevention and treatment option for eclampsia. It may help to reduce the risk of serious outcomes, including the death of the pregnant person. Eclampsia is ...
Providing magnesium sulfate to pregnant patients before delivery in the periviable period of 22-24 weeks’ gestation was not linked to better neurodevelopmental outcomes in the newborn after accounting ...
Babies born during 22-24 weeks of gestation have a higher risk of neurodevelopmental impairment. While prior studies have found that magnesium sulfate helps prevent the development of cerebral palsy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results